rutin

Overview

Rutin is a naturally occurring flavonoid glycoside, widely distributed in plants and commonly discussed in biomedical research for its antioxidant, anti-inflammatory, anti-angiogenic, and broader cytoprotective properties. It is frequently identified in botanical and food matrices such as Sophora japonica, Fagopyrum esculentum (buckwheat), Morus alba leaves, citrus cultivars, pitaya peels, and other polyphenol-rich materials. In recent studies, rutin has been considered both as a bioactive constituent of complex extracts and as a standalone compound with potential therapeutic relevance.

Biologically, rutin is often investigated in relation to oxidative stress, inflammatory signaling, and disease pathways involving nuclear factor kappa B (NF-κB), TLR4, RUNX1, and related mediators. Across the provided studies, it was associated with antioxidant defense, modulation of proinflammatory cytokines, protection of the intestinal barrier, effects on metabolic dysfunction–associated steatotic liver disease, and antiangiogenic activity. It is also being explored in formulation strategies, including PEG-β-cyclodextrin and other delivery systems, to improve its in vivo performance.

Focus of Latest Publications

Recent investigations into rutin have focused on overcoming its therapeutic limitations and elucidating its molecular mechanisms of action across multiple disease contexts. Rutin, a natural flavonoid with documented antioxidant and anti-inflammatory properties, has demonstrated efficacy in treating conditions ranging from neurodegenerative diseases to chronic inflammatory disorders; however, its clinical application is hindered by extremely low water solubility and poor bioavailability. To address these constraints, multiple studies have developed advanced delivery systems, including polymer/lipid hybrid nanoparticles surface-engineered with glucosamine/chitosan blends, PEG-β-cyclodextrin polymer complexes, and nanoparticle conjugates, which have shown significantly enhanced bioavailability, controlled release profiles, and improved therapeutic effects compared to free rutin.

Mechanistic investigations have identified rutin as a direct binder of multiple intracellular targets, with studies demonstrating its ability to inhibit YANK2 kinase activity in glioblastoma (showing synergistic antitumor effects when combined with temozolomide), disrupt the RUNX1/TET2 complex to suppress TLR4/NF-κB signaling in non-alcoholic fatty liver disease, and target PD-L1 in atopic dermatitis. Network pharmacology analyses of rutin-containing herbal preparations have identified hub targets including MAPK8, SRC, IGF1, and HSP90AA1 in antioxidative stress pathways. In neuroinflammatory contexts, rutin has been incorporated into multifunctional delivery systems that simultaneously suppress amyloid-β aggregation and production while mitigating microglia and astrocyte activation, thereby reducing synapse loss and restoring cognitive function in Alzheimer's disease models.

Clinical and preclinical applications span diverse disease areas: in Henoch-Schönlein purpura, rutin ameliorated vascular injury and systemic inflammation through multiple mechanisms including restoration of intestinal barrier integrity via increased zonula occludens-1 and occludin expression, modulation of gut microbiota, and regulation of short-chain fatty acid metabolism. Rutin-containing natural products demonstrated synergistic pharmacological interactions with established therapeutics—for example, extracts enriched in rutin showed potentiated effects when combined with acarbose (α-glucosidase inhibition for diabetes) and donepezil (β-secretase inhibition for Alzheimer's disease). Antiangiogenic formulations of rutin have shown enhanced anticancer potential, while investigations into rutin's interactions with stress-response chaperones such as GRP78 suggest additional applications in cancer chemoresistance. Collectively, these studies establish rutin as a multitarget bioactive compound whose therapeutic potential is being substantially amplified through targeted delivery innovations and rational combination approaches.